Jacob deGrom Enters 2025 Spring Training Without Restrictions

Full Clearance and the 2025 Spring Training Baseline

When Texas Rangers pitchers reported to the team's Spring Training facility in Surprise, Arizona, all eyes centered on right-hander Jacob deGrom. Coming off a painstaking 15-month recovery from his second ulnar collateral ligament reconstruction, deGrom entered camp as a full participant. Manager Bruce Bochy and the Rangers medical staff confirmed that the two-time Cy Young Award winner operates under zero pitching constraints, clearing the way for a standard Cactus League progression leading into Opening Day.

The absence of a pitch count restriction or delayed ramp-up schedule represents a milestone for both the player and the franchise. Rather than following a modified, slow-build throwing program typically reserved for arm rehabilitation, deGrom is scheduled to take regular rotation turns alongside his teammates. His off-season routine involved structured bullpens and live bullpen sessions in Florida, allowing him to report to camp physically prepared for full-effort mound sessions.

For Texas, having deGrom fully unconstrained at the opening of camp signals a major transition from rehab management to competitive preparation. The team managed his recovery with immense caution throughout 2024, choosing to activate him for a handful of major league starts only after he checked every performance and physiological threshold. That deliberate path has paid off, providing Texas with a healthy ace as they aim to reclaim dominance in the American League West.

The Two-Year Journey from Tommy John Surgery to MLB Return

deGrom's path to complete clearance was long and complex. In December 2022, Texas committed $185 million over five years to secure deGrom as the centerpiece of their rotation. However, after just six starts in the spring of 2023 during which he posted a 2.67 ERA with 45 strikeouts in 30.0 innings, deGrom suffered a tear in his right ulnar collateral ligament. He underwent his second career revision surgery in June 2023, missing the remainder of Texas's championship run.

His multi-stage rehabilitation process spanned the entirety of late 2023 and most of the 2024 season. By August 2024, deGrom initiated a formal minor league rehab assignment across multiple affiliates, showcasing sharp command and fastballs touching upper-90s velocity. The Rangers called him up to the active roster in mid-September for a brief major league rehearsal, designed to test his surgically repaired elbow against top-tier competition before entering the off-season.

In those three September starts, deGrom yielded impressive results. Across 10.2 innings of work, he surrendered three earned runs (2.57 ERA), issued only one walk, and struck out 14 batters. More importantly, post-start biological testing and MRI scans confirmed that his reconstructed elbow absorbed the stress without swelling or adverse structural reactions, setting the foundation for an uninhibited 2025 preparation.

Evaluating Mechanics, Velocity, and Pitch Design Post-Rehab

Statcast metrics from deGrom's late-2024 outings revealed encouraging signs regarding his pure physical capabilities. His four-seam fastball routinely sat between 97.5 mph and 98.8 mph, occasionally eclipsing 99 mph. While this velocity sits slightly lower than his peak 2021 averages when he routinely touched 101 mph, it remains among the elite tier for major league starting pitchers and demonstrates full neuromuscular recovery.

Beyond velocity, deGrom showed immediate command of his signature slider, which featured its characteristic tight, late bite in the 90-92 mph range. His ability to tunnel the slider off his elevated four-seamer remained intact, as demonstrated by high swing-and-miss rates against major league hitters during his September tune-up. Furthermore, deGrom utilized his changeup effectively to keep left-handed hitters off balance, illustrating a complete three-pitch arsenal.

Pitching analysts and biomechanical experts noted slight modifications in deGrom's mechanical sequence during his return. His delivery appeared slightly more compact at shoulder rotation, minimizing excessive trunk hyper-extension while keeping his arm path clean. These subtle mechanical refinements are intended to distribute rotational torque more evenly across his back and shoulder, reducing localized stress on his elbow ligament without compromising elite arm speed.

Managing High-Velocity Rotational Stress and Pitcher Durability

While deGrom begins the season without formal pitch limits, managing workload durability remains a critical task for the Rangers training staff. Pitchers returning from a second revision Tommy John surgery carry inherent risk profiles due to scar tissue formation and altered biomechanical strain pathways. Consequently, Texas plans to monitor qualitative indicators—such as recovery time between starts, spin consistency, and arm slot stability—rather than relying solely on arbitrary pitch totals.

Modern sports science emphasizes that workload management extends beyond pitch counts to focus on high-stress inning volume and recovery intervals. Texas manager Bruce Bochy indicated that while deGrom will take his normal rotation turns, the club may periodically utilize off-days in the schedule to provide extra rest. Giving high-velocity starters six days of rest between outings has gained popularity across MLB as a method to mitigate fatigue-induced ligament strain.

deGrom's personal outlook remains focused on throwing maximum quality strikes without holding back. Known for his intense competitiveness on the mound, deGrom has stated that attempting to pitch with reduced effort or manipulated velocity counterproductively alters mechanics and increases injury risk. By trusting his natural, high-velocity delivery, deGrom aims to operate as the dominant front-line starter Texas envisioned when signing him.

Strategic Roster Impact on the Texas Rangers Rotation

The presence of a healthy Jacob deGrom fundamentally transforms the Texas Rangers starting pitching staff. Joining veteran right-hander Nathan Eovaldi at the top of the rotation, deGrom provides Texas with a formidable one-two punch capable of matching up against any postseason rotation in baseball. His presence shifts middle-of-the-rotation starters into roles that better align with their skill sets, creating roster depth across the pitching corps.

In 2024, the Rangers rotation suffered from lingering health issues and inconsistency, contributing to the team missing the postseason after their 2023 World Series victory. The return of deGrom as a fully operational primary starter gives Texas an elite weapon capable of suppressing opponent scoring and providing crucial length to preserve the bullpen. A stable rotation anchoring the staff takes immense pressure off the team's relief unit.

From a payroll perspective, deGrom entering the third year of his five-year deal fully healthy represents a major return on investment for the front office. General Manager Chris Young structured the roster to peak during this window, and having their signature free-agent acquisition fully operational establishes Texas as an immediate contender in the competitive American League West.

Historical Precedents and Long-Term Projections for Two-Time Tommy John Pitchers

Pitchers returning from a second Tommy John surgery were historically viewed with substantial skepticism, as success rates for revision elbow reconstructions were significantly lower than primary procedures. However, modern surgical techniques, including internal brace enhancements and customized anchor placements, have drastically improved return-to-play outcomes for elite professional athletes over the past decade.

Recent successful returnees from revision UCL surgeries, such as Nathan Eovaldi and Jameson Taillon, demonstrate that starting pitchers can maintain high performance and career longevity following two major elbow procedures. These precedents show that while careful monitoring is necessary, elite pitch quality and high-level productivity remain completely achievable when structural integrity and mechanics are properly maintained.

As the 2025 season unfolds, deGrom's performance will serve as a prominent benchmark for modern sports medicine and high-velocity pitching durability. If deGrom maintains his standard performance level across 150 or more innings, it will reinforce new clinical standards for second Tommy John recoveries, validating both Texas's medical strategy and deGrom's relentless dedication to returning to the pinnacle of Major League Baseball.

What remains unclear

• The exact total inning cap or season workload threshold Texas will set for deGrom in 2025.
• Whether deGrom can maintain high-90s velocity across a full season of 25 to 30 starts without physical strain.

What happens next

deGrom will pitch on a standard starter schedule throughout Cactus League exhibition games in February and March, targeting Opening Day readiness for the Texas Rangers rotation.